F-1/A: INLIF Limited Files Amendment No. 4 to Form F-1 for Proposed IPO

INLIF Limited, a Cayman Islands holding company with operations in China, has filed an amendment to its F-1 registration statement for a proposed initial public offering of its ordinary shares.

Summary

• INLIF Limited, a Cayman Islands holding company, has filed Amendment No. 4 to its Form F-1 registration statement with the SEC.
• The company is planning an initial public offering of 2,000,000 ordinary shares.
• The expected initial public offering price is estimated to be between $4 and $6 per share.
• INLIF Limited has applied to list its Ordinary Shares on the Nasdaq Capital Market under the symbol INLF, but approval is not yet final.
• The company's operations are primarily conducted through its operating entity, Ewatt Robot Equipment Co. Ltd., in the PRC.
• The document highlights risks associated with doing business in the PRC, including regulatory uncertainties and potential government intervention.
• The company has submitted the filing application with the CSRC for this offering, as required by the Trial Measures.
• On January 2, 2024, we were advised by the CSRC that the Company has fulfilled the filing procedures required pursuant to the Trial Measures.
• Following the completion of this offering, our officers, directors and other holders of 5% or more of our Ordinary Shares will collectively control approximately 86.2% of our Ordinary Shares (assuming no exercise of underwriters over-allotment option) and as a result will be able to exert significant influence over the management and affairs of the company and most matters requiring shareholder approval following the offering.

Sentiment

Score: 5

Explanation: The document is primarily a regulatory filing, so the sentiment is neutral. It contains both positive aspects (progress towards IPO) and negative aspects (risks associated with PRC regulations).

Positives

• The company has submitted the filing application with the CSRC for this offering, as required by the Trial Measures.
• On January 2, 2024, we were advised by the CSRC that the Company has fulfilled the filing procedures required pursuant to the Trial Measures.

Negatives

• The document highlights risks associated with doing business in the PRC, including regulatory uncertainties and potential government intervention.
• Following the completion of this offering, our officers, directors and other holders of 5% or more of our Ordinary Shares will collectively control approximately 86.2% of our Ordinary Shares (assuming no exercise of underwriters over-allotment option) and as a result will be able to exert significant influence over the management and affairs of the company and most matters requiring shareholder approval following the offering.

Risks

• Chinese regulatory authorities could disallow our corporate structure, which would likely result in a material change in our operations and/or a material change in the value of our Ordinary Shares, including that it could cause the value of our Ordinary Shares to significantly decline or become worthless.
• The impact of the CACs increasing oversight over data security remains highly uncertain, particularly for companies with substantial China operations seeking to list on a foreign stock exchange.
• The PRC government exerts substantial influence over the manner in which the PRC subsidiaries conduct their business activities.
• The Ordinary Shares may be delisted under the HFCA Act.
• PRC regulation of loans to, and direct investments in, PRC entities by offshore holding companies may delay or prevent us from making loans or additional capital contributions to our PRC subsidiaries and thereby prevent us from funding our business.
• It may be difficult for overseas regulators to conduct investigations or collect evidence within the PRC.
• You may experience hardships in effecting service of legal process, enforcing foreign judgments, or bringing actions in China against us or our management named in this prospectus based on foreign laws.

Future Outlook

The company intends to use the net proceeds from this offering for the construction of its 5G digital intelligent equipment production base, establishing local marketing and service offices, constructing an industrial robot and automation application technology research and development center, and as working capital.

Industry Context

The document does not provide specific details about the competitive landscape or industry trends beyond the company's own operations.

Stakeholder Impact

• Shareholders face risks related to PRC regulations and potential government intervention.
• The company's ability to operate in China may be harmed by changes in its laws and regulations.

Next Steps

• The company needs to obtain final approval from Nasdaq for its listing application.
• The underwriters expect to deliver the Ordinary Shares against payment in U.S. dollars in New York, New York on or about [], 2024.

Key Dates

Keywords

IPO, initial public offering, INLIF Limited, CSRC, China, ordinary shares, regulation